Mentalisation-based therapy for eating disorder treatment: protocol for a systematic review
Abstract
Introduction Eating disorders (EDs) are complex psychological and physiological disorders that often co-occur in the presence of other mental health difficulties. Mentalisation-based therapy (MBT) offers a promising therapeutic approach for treating comorbid difficulties by fostering individuals’ capacity to understand their own and others’ mental states. More specifically, MBT is a novel approach for treating EDs that recognises the intricate interplay between psychological factors and disordered eating behaviours, targeting the underlying cognitive and emotional processes implicated in ED pathology. The possible value of MBT in treating EDs has been proposed, but the existing research on the topic has not yet been synthesised. This review aims to examine the effectiveness of MBT across diverse ED presentations through analysis of the peer-reviewed literature. Methods and analysis This systematic review protocol adheres to the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols checklist. The review will include peer-reviewed studies on MBT for EDs without geographical restrictions. A systematic search for the published literature will be conducted using the following databases: Medline, Embase, PsycInfo and Cochrane Central Register of Controlled Trials. For articles to be included, documents must describe and evaluate MBT for EDs and be a quantitative study. There will be no restrictions on publication date. The two authors will independently…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.